<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02272322</url>
  </required_header>
  <id_info>
    <org_study_id>BCR-11-01</org_study_id>
    <nct_id>NCT02272322</nct_id>
  </id_info>
  <brief_title>Transvaginal Treatment of Symptomatic Cystocele Grade II-III</brief_title>
  <acronym>BCR</acronym>
  <official_title>Transvaginal Treatment of Symptomatic Cystocele Grade II-III Using Cousin Biomesh Soft Prolaps or Allium Medical Endofast Reliant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Slabbaert Koen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Regionaal Ziekenhuis Heilig Hart Tienen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This observational study will evaluate treatment of symptomatic cystocele grade II-III with
      Cousin Biomesh and Allium Medical Endofast Reliant. Data about 100 patients will be
      collected. Follow-up till 3 years after the procedure. Primary endpoint is absence of
      recurrence.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>June 2014</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Absence of recurrence</measure>
    <time_frame>3 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical success</measure>
    <time_frame>day 1</time_frame>
    <description>Correct positioning of the mesh as intended by the surgeon</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural success</measure>
    <time_frame>30 days</time_frame>
    <description>Technical success without complications till 30 days after the index-procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Peroperative complications</measure>
    <time_frame>day 1</time_frame>
    <description>Perforation bowels, bladder or arteries</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative complications</measure>
    <time_frame>3 years</time_frame>
    <description>Infection, bleeding, recurrence, mesh erosion, pain during sexual activities, pain, discomfort</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life</measure>
    <time_frame>3 years</time_frame>
    <description>PFDI-20, PFIQ-7, PISQ-12</description>
  </secondary_outcome>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Cystocele</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cystocele repair with biomesh soft prolaps and endofast reliant</intervention_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with symptomatic anterior prolapse
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient is a woman

          -  Patient is between 40 and 90 years old

          -  Patient has to sign the informed consent form prior to the procedure

          -  Patient has to agree with the scheduled follow-up visits on month 1, month 6, year 1,
             year 2 and year 3

          -  Patient has symptomatic anterior prolapse

        Exclusion Criteria:

          -  Recurrence cystocele

          -  Patient is pregnant

          -  Patient has a wish to become pregnant

          -  Patient is taking Plavix, Sintrom, Marcoumar, Marevan, Brilique, Efient, Ticlid,
             Xarelto, Eliquis or Pradaxa. If intake is stopped prior to procedure, patient is
             allowed to be included.

          -  Patient is taking LMWH in a dose of more than 40 mg/day

          -  Patient has a life expectancy &lt; 1 year

          -  Patient has a known connective tissue disease

          -  Patient has a history of surgery of the anterior vaginal wall or pelvis

          -  A scheduled hysterectomy during the index-procedure
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Koen Slabbaert, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>RZ Heilig Hart Tienen</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>RZ Heilig Hart Tienen</name>
      <address>
        <city>Tienen</city>
        <state>Vlaams-Brabant</state>
        <zip>3300</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2014</study_first_submitted>
  <study_first_submitted_qc>October 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 22, 2014</study_first_posted>
  <last_update_submitted>January 31, 2017</last_update_submitted>
  <last_update_submitted_qc>January 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Regionaal Ziekenhuis Heilig Hart Tienen</investigator_affiliation>
    <investigator_full_name>Slabbaert Koen</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Anterior prolapse</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cystocele</mesh_term>
    <mesh_term>Hernia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

